Stay updated on IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:48:36.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    Site revision metadata updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T18:03:26.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T14:35:07.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the prior Revision: v3.4.1 and a government funding lapse/operating status notice were removed.
    Difference
    0.4%
    Check dated 2026-02-11T09:22:12.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Global site notice about a lapse in government funding and the NIH Clinical Center's status was added, and the site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T05:37:11.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The update adds a glossary toggle and includes minor metadata/versioning changes (e.g., v3.4.0) along with capitalization adjustments in labeled text.
    Difference
    0.2%
    Check dated 2026-01-28T03:58:22.000Z thumbnail image

Stay in the know with updates to IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.